Literature DB >> 1317029

Hydroxylapatite ossicular replacement prostheses: a four-year experience.

R A Goldenberg.   

Abstract

Between 1987 and 1991, I have used 215 hydroxylapatite middle ear implants, in various styles, for hearing reconstruction. The first such implants were composed entirely of hydroxylapatite. Because of intraoperative difficulties in shaping and trimming these prostheses, hybrid prostheses using Plasti-Pore were developed. For each of four implant designs (incus, incus-stapes, PORP, and TORP), the head is constructed from hydroxylapatite and the shaft from Plasti-Pore. Extrusion rate for the hybrid prostheses is low (4.3%). Hearing results from 47 patients with the hybrid hydroxylapatite prostheses, 140 patients with total hydroxylapatite prostheses, and 75 control group patients with homograft bone or Plasti-Pore prostheses were compared. A "successful" hearing result was achieved in 51.1%, 51.4%, and 60.0% of the three groups, respectively. Surgical technique for use of the new hybrid hydroxylapatite prostheses is described.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317029     DOI: 10.1177/019459989210600312

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  4 in total

1.  Hearing Results Post Tympanoplasty: Our Experience with Adults at the KKR ENT Hospital, India.

Authors:  E S Kolo; R Ramalingam
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-11-10

2.  Stapes stabilizing cartilage graft.

Authors:  Ibrahim Erdim; Emrah Sapmaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-11-12       Impact factor: 2.503

3.  Study on effects of partial ossicular replacement prostheses with different materials on hearing restoration.

Authors:  Wenjuan Yao; Cuiping Guo; Xuemei Luo
Journal:  J Mater Sci Mater Med       Date:  2012-10-30       Impact factor: 3.896

4.  Surgical management of middle ear cholesteatoma and reconstruction at the same time.

Authors:  Pedro Blanco; Francisco González; Jorge Holguín; Claudia Guerra
Journal:  Colomb Med (Cali)       Date:  2014-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.